Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

The People Events

  1. Events
  2. Organisers
  3. The People Events
Events from this organiser
Today

3rd Global Pharma Tech Summit

The Global Pharma Tech Summit 2025 is scheduled to convene on June 23 - 24, 2025, in Zurich, Switzerland. This prestigious event extends an invitation [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top